437 results on '"Thon N"'
Search Results
2. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
3. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance):a report of the RANO resect group
4. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET.
5. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis
6. Multimodale Radiomicsanalysen zur Prädiktion des IDH-Mutationsstatus bei erstdiagnostizierten Gliomen
7. Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability.
8. Herausforderungen in der praktischen Durchführung einer palliativmedizinischen, klinischen, randomisierten Studie mit Glioblastom-Patient*innen.
9. P15.09.A Canny edge detection algorithm for quantitative differentiation between diffuse and circumscript glioma growth patterns on MRI
10. P11.50.A Surgical results and long-term outcome in supratentorial intraventricular tumors
11. P11.51.B Initial temozolomide monotherapy without radiotherapy might be of limited benefit in the treatment of astrocytoma, IDH-mutant, CNS WHO grade 2 and 3
12. OS03.4.A In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
13. The place of interstitial brachytherapy and radiosurgery for low-grade gliomas
14. Perifocal Edema in Patients with Meningioma is Associated with Impaired Whole-Brain Connectivity as Detected by Resting-State fMRI.
15. Perifocal edema in meningioma patients is correlated with impaired whole brain connectivity as detected by resting-state functional MRI
16. Questionable long-term benefit of initial temozolomide monotherapy in IDH-mutant astrocytomas grade 2 and 3
17. Physician Health: Results and Caveats from Surveys in Austria, Switzerland and Germany
18. Prevalence of superficial siderosis following singular, acute aneurysmal subarachnoid hemorrhage
19. MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy
20. Prognostische Wertigkeit der TSPO-PET bei Patienten mit Gliomrezidiv
21. 18F-GE-180 TSPO PET in High-Grade Glioma RT Planning
22. Effekt einer frühen Palliativversorgung bei Patient*innen mit Glioblastom (EPCOG).
23. P05.01 Prospective validation trial of magnetic resonance imaging based Contrast Clearance Analysis (CCA) to differentiate between pseudoprogression/radiation necrosis and progressive disease following cranial radiotherapy
24. PD-0800 Radiotherapy in IDH wild-type multifocal high-grade glioma
25. PH-0165 Differentiation of Pseudoprogression vs. True Progressive Disease using Contrast Clearance Analysis
26. The surgical perspective in precision treatment of diffuse gliomas
27. Assessing and Treating Alcohol Relapse Risk in Liver Transplantation Candidates
28. Subventricular zone involvement is associated with unfavourable outcome in glioma of WHO grade II
29. Diffuse MRI-based tumour growth pattern is associated with worse outcome only in IDH wildtype but not in IDH mutant gliomas WHO II and III
30. Extent and prognostic relevance of MGMT promotor methylation does not differ between glioblastoma and IDH-wildtype TERT-mutated astrocytoma
31. PCV chemotherapy alone for WHO grade 2 oligodendroglioma - prolonged disease control with low risk of malignant transformation
32. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy†
33. Expression of VEGFR3 in glioma endothelium correlates with tumor grade
34. Risks and benefits of microsurgical resection of glioblastoma in older adults – a retrospective multi-centre study
35. Infiltration of the subventricular zone in low-grade gliomas – molecular markers, management and outcome
36. Clinical presentation, management and outcome in primary dural lymphomas
37. PH-0359: Blood plasma based risk stratification of glioblastoma patients
38. PO-0876: Stereotactic radiosurgery with singleisocenter dynamic arc therapy of multiple brain metastases
39. S22.1ASSESSING DRINKING STATUS IN LIVER TRANSPLANT PATIENTS WITH ALCOHOLIC LIVER DISEASE
40. Diffusion and Heat Exchange in Chemical Kinetics
41. Personalized surgical therapy
42. 360O Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
43. CHARACTERIZATION OF PHOSPHATIDYLETHANOL IN CLINICAL DIMENSIONS: NORMALIZATION DURING DETOXIFICATION, GENDER ASPECTS AND CORRELATION WITH OTHER BIOMARKERS AND SELF-REPORTS: P063
44. Whole-brain connectivity as a measure for disease burden – moving beyond structure and towards function in MRI imaging of glioma patients
45. Favorable outcome after interstitial photodynamic therapy of glioblastoma may be caused by long-term activation of the adaptive immune response
46. Significance of CSF markers for detection of ventriculitis in patients with EVD after traumatic brain injury
47. Influence of individual CpG methylation status on outcome in adult patients with glioblastoma multiforme receiving alkylating agent treatment
48. Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma
49. ALTERATION OF PLATELET PROTEINS DURING STORAGE ASSESSED BY PROTEOMICS: EVIDENCE OF ONGOING PROTEIN TRANSLATION OVER THE STORAGE PERIOD: 4A-S16-4
50. Scalp reconstruction after resection of malignant scalp tumours - an analysis and treatment algorithm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.